SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is experiencing a historic surge driven by a relentless short squeeze and a significant China silver export ban, sparking intense euphoria and FOMO within the community. Discussions are polarizing between those forecasting substantial new highs and others cautioning about a potential "bubble" or "rug pull," drawing comparisons to past spectacular rallies like Bitcoin and GME. This momentum is further amplified by broader concerns over economic instability, dollar weakness, and silver's re-evaluated role as a critical safe-haven and industrial asset.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp (UAMY) is gaining significant attention following its acquisition of a critical minerals flotation facility, further solidifying its vertical integration. Investors are keenly discussing the company's unique position as the sole US antimony producer for military applications, speculating on potential government investments and a short squeeze. This renewed interest is fueled by a broader focus on securing domestic critical mineral supply chains and recent institutional activity, including a notable share purchase by the State of Alaska.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is hitting unprecedented record highs, fueling intense community discussion on whether this represents a fundamental shift towards safe-haven assets amidst global uncertainty and dollar weakness, or an overheated, speculative frenzy. Sentiment is sharply divided between those expecting continued strength from central bank diversification and others anticipating a significant market correction after such a rapid ascent.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending as reports indicate a significant $1.6 billion US government investment, including a 10% equity stake and debt financing, aimed at bolstering domestic critical mineral production. This news has triggered an overnight trading halt and fueled highly bullish community sentiment, with many anticipating a substantial short squeeze and new all-time highs. Investors see this as a strategic 'America First' move in a hot rare earth sector, reinforcing supply chain security.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending due to strong Glioblastoma trial data, with median overall survival not yet reached, alongside recent Saudi approvals for lung cancer that significantly expand its global market. The community is actively discussing the potential for a substantial short squeeze, fueled by high short interest and anticipation of further positive news regarding its broad-spectrum Anktiva platform, a "chemo-free" immunotherapy seen as a paradigm shift in cancer treatment.

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network Inc. is experiencing a significant short squeeze, fueled by a recent AI-related deal and an extremely low float. The community is actively debating its parabolic run, with many anticipating continued upward momentum reminiscent of past volatile stock surges, while others warn of extreme volatility and potential risks. This explosive price action has drawn broad attention, especially given the current interest in AI sector plays.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines faces market volatility following reports that acquisition talks with a major pharmaceutical company concluded without an agreement on price. Despite the immediate reaction, investors are actively debating the long-term value of RVMD's promising oncology pipeline for RAS-addicted cancers, with many speculating about potential interest from other suitors in a competitive biotech M&A environment.

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals is trending after announcing positive topline results from its Phase 2b study of zelicapavir for RSV, highlighting significant antiviral activity and symptom improvement, despite missing the primary endpoint. This news, coupled with recent analyst upgrades, contrasts with community concerns regarding a dilutive public offering, sparking intense debate over the company's valuation and future prospects in the competitive RSV antiviral landscape.

American Axle & Manufacturing Holdings, Inc. engages in the manufacture, engineering, design, and validation of driveline systems and related components. It operates through the Driveline and Metal Forming segments. The Driveline segment consists of axles, drive shafts, power transfer units, rear drive modules, and electric and hybrid driveline products and systems for light trucks, service utility vehicles, crossover vehicles, passenger cars, and commercial vehicles. The Metal Forming segment manufactures axle shafts, ring and pinion gears, differential gears, transmission gears, and shafts and suspension components for original equipment manufacturers (OEMs), and Tier 1 automotive suppliers. The company was founded by Richard E. Dauch on March 1, 1994, and is headquartered in Detroit, MI.

American Axle & Manufacturing Holdings Inc

American Axle & Manufacturing is actively trending after securing a crucial regulatory approval from China for its significant acquisition of Dowlais Group, which clears a major hurdle for the deal. This strategic move is generating buzz as it's expected to expand the company's global presence and accelerate its focus on electrified vehicle technology. The community is closely watching AXL for potential long-term value creation and noting its recent strong price action amidst this pivotal development.

Freeport-McMoRan, Inc. engages in the mining of copper, gold, and molybdenum. It operates through the following segments: North America Copper Mines, South America Operations, Indonesia Operations, Molybdenum Mines, Rod and Refining, Atlantic Copper Smelting and Refining, and Corporate and Other. The North America Copper Mines segment operates open-pit copper mines in Morenci, Bagdad, Safford, Sierrita, Miami in Arizona and Chino, and Tyrone in New Mexico. The South America Operations segment includes Cerro Verde in Peru and El Abra in Chile. The Indonesia Operations segment handles the operations of the Grasberg minerals district that produce copper concentrate containing significant quantities of gold and silver. The Molybdenum Mines segment includes the Henderson underground mine and Climax open pit mine, both in Colorado. The Rod and Refining segment consists of copper conversion facilities located in North America and includes a refinery and rod mills. The Atlantic Copper Smelting and Refining segment smelts and refines copper concentrate and markets refined copper and precious metals in slimes. The Corporate and Other segment offers other mining and eliminations, oil and gas operations, and other corporate and elimination items. The company was founded by James R. Moffett on November 10, 1987, and is headquartered in Phoenix, AZ.

Freeport-McMoRan Inc

Freeport-McMoRan is trending amidst its strong earnings and updated guidance, which are reassuring investors despite past production challenges at its Grasberg mine, now slated for a phased restart. Community discussions highlight record-high copper prices and a growing conviction around a structural supply deficit driven by insatiable demand from electrification, AI, and data centers. This positions FCX as a pivotal asset in the critical minerals landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CIBC Asset Management Inc Reduces Stock Holdings in IQVIA Holdings Inc. $IQV

CIBC Asset Management Inc cut its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 16.2% in the third quarter, according to its most recent disclosure with the Securities and...

IQVIA (NYSE:IQV) Rating Increased to Buy at Wall Street Zen

Wall Street Zen raised IQVIA from a "hold" rating to a "buy" rating in a research note on Sunday...

IQVIA Holdings Inc. $IQV Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH lowered its holdings in IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 4.8% during the third quarter, according to its most recent disclosure with...

Cantillon Capital Management LLC Purchases 413,256 Shares of IQVIA Holdings Inc. $IQV

Cantillon Capital Management LLC grew its position in IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 27.3% during the 3rd quarter, according to the company in its most recent disclosure with the...

Carmel Capital Partners LLC Sells 4,835 Shares of IQVIA Holdings Inc. $IQV

Carmel Capital Partners LLC trimmed its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 32.5% in the third quarter, according to its most recent filing with the Securities and...

IQVIA Named to the Fortune Worlds Most Admired Companies List, Ranked No. 1 in Its Sector for Fifth Consecutive Year

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, was named No. 1 in its category on the 2026 Fortune Worlds Most Admired...

Massachusetts Financial Services Co. MA Has $37.82 Million Position in IQVIA Holdings Inc. $IQV

Massachusetts Financial Services Co. MA increased its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 16.7% in the 3rd quarter, according to its most recent filing with the SEC...

Allstate Corp Buys Shares of 6,274 IQVIA Holdings Inc. $IQV

Allstate Corp purchased a new position in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm...

Rakuten Investment Management Inc. Buys New Shares in IQVIA Holdings Inc. $IQV

Rakuten Investment Management Inc. purchased a new position in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) in the third quarter, according to the company in its most recent disclosure with...

IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026

IQVIA Holdings Inc. (IQVIA) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will...

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

IQVIA Holdings Inc

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

Current Price	$235.31
Prev Close	$239.05
Open	$238.50
Dividend Yield	0.00%
50-Day Moving Average	$228.37
Beta	1.14
Avg. Volume	1.33M
PE Ratio	32.30

52-Week High	$247.05
52-Week Low	$134.65
Market Capitalization	$59.39B
EPS (Annual)	$7.49
Price to Book	6.51
Revenue Per Employee	$175,056.82
Enterprise Value/EBITDA	N/A

IQV
IQVIA Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IQV News

IQVIQVIA Holdings Inc